NIH-funded research R01 grant

Helping cancer survivors manage symptoms and reduce distress during treatment

Official title: Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors

Funded at University of Arizona · NIH-11078665 · Data updated 2026-11-12

This study is testing a helpful phone system that lets cancer survivors share their symptoms each week, so their healthcare team can quickly support them, especially if they're feeling really stressed, making it easier for them to manage their health during treatment.

More Self-management research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startMay 1, 2022
Project endApril 30, 2027
Funding year2025
Award (this year)$643,900
NIH project number5R01CA263714-04
Project IDNIH-11078665 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are cancer survivors who are within 12 weeks of starting immune checkpoint inhibitor therapy and are experiencing elevated psychological distress.

Less likely to help

Patients who are not currently undergoing treatment with immune checkpoint inhibitors or those without significant psychological distress may not benefit from this research.

What this research studies

This research focuses on improving the management of symptoms experienced by cancer survivors undergoing treatment with immune checkpoint inhibitors. It utilizes an Automated Telephone Symptom Management system that allows patients to report their symptoms weekly, which helps healthcare providers monitor and address any issues promptly. The study involves a randomized trial design, where participants may receive additional support if their psychological distress remains high. The goal is to empower survivors with effective self-management strategies and timely communication with their healthcare team.

Why it matters

Potential benefit: If successful, this research could lead to better symptom management and reduced psychological distress for cancer survivors on immune checkpoint inhibitors.

How similar studies have gone: Previous research has shown that similar approaches to symptom management and patient self-reporting can lead to improved outcomes, indicating potential success for this study.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Badger, Terry a — University of Arizona
  • Study coordinator: Badger, Terry a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.